Valuation: Enzymatica AB

Market Cap 568M 497M 456M 426M 806M 54.07B 818M 5.48B 2.13B 26.56B 2.13B 2.09B 91.64B P/E 2024
-5.73x
P/E 2025 -8.89x
Enterprise Value 536M 469M 430M 402M 761M 51.02B 772M 5.17B 2.01B 25.05B 2.01B 1.97B 86.46B EV / Sales 2024
5.88x
EV / Sales 2025 7.96x
Free-Float
56.66%
Yield 2024 *
-
Yield 2025 -
1 day-0.85%
1 week-6.40%
Current month-2.50%
1 month-11.70%
3 months-24.03%
6 months+21.88%
Current year+23.16%
1 week 2.27
Extreme 2.27
2.6
1 month 2
Extreme 2
2.88
Current year 1.6
Extreme 1.6
3.4
1 year 1.6
Extreme 1.6
3.4
3 years 1.34
Extreme 1.34
5.45
5 years 1.34
Extreme 1.34
13.4
10 years 1.34
Extreme 1.34
24.7
Manager TitleAgeSince
Chief Executive Officer - 31/01/2026
Chief Operating Officer 61 31/12/2010
Director of Finance/CFO - 12/04/2026
Director TitleAgeSince
Chairman 58 14/02/2016
Chairman 64 18/12/2016
Director/Board Member 71 18/12/2016
Date Insider Type Main position Quantity % Market Cap.
03-31Sell

Responsable ventes & marketing

40,000 0.0165%
12-29Buy

Chairman

20,000 0.0082%
12-26Buy

Chairman

20,000 0.0082%
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-6.40%-20.14%-9.13% 58.89M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+32.57%+24.89% 338B
-0.56%+0.96%+41.67%+39.35% 299B
-0.08%+1.30%+32.15%+44.48% 291B
-1.54%+2.81%-25.35%-39.61% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.80%+3.48%+26.59%+51.49% 369.25B
Weighted average by Cap. +2.25%+5.53%+42.31%+83.30%

Financials

2024 2025
Net sales 45.58M 39.86M 36.58M 34.15M 64.71M 4.34B 65.67M 440M 171M 2.13B 171M 167M 7.35B 53.9M 47.14M 43.27M 40.39M 76.53M 5.13B 77.67M 520M 202M 2.52B 202M 198M 8.7B
Net income -53.18M -46.51M -42.69M -39.85M -75.5M -5.06B -76.63M -513M -199M -2.49B -200M -195M -8.58B -51.89M -45.38M -41.65M -38.88M -73.67M -4.94B -74.77M -500M -195M -2.43B -195M -191M -8.37B
Net Debt -73.01M -63.85M -58.61M -54.71M -104M -6.95B -105M -704M -274M -3.41B -274M -268M -11.78B -32.11M -28.08M -25.78M -24.06M -45.59M -3.06B -46.27M -310M -120M -1.5B -121M -118M -5.18B
Logo Enzymatica AB
Enzymatica AB (publ) is a Sweden-based life science company that develops and sells medical devices for infection-related diseases. The Company deals with research, development and sales of products based on enzyme technology and related activities. Enzymatica AB (publ) develops solutions that support the body's own defenses against virus, irritants and microorganisms. The Company offers products which are based on a barrier technology, includes marine enzymes. Enzymatica AB (publ) focuses on product development based on the tested and patented barrier technology used in the common cold product ColdZyme, a mouth spray that protects against colds, can help shorten the duration of the cold if used in the early stages of infection, relieves cold symptoms, and soothes sore throats.
Employees
21
Date Price Change Volume
03/07/26 SEK 2.340 -0.85% 79,440
02/07/26 SEK 2.360 -1.67% 18,303
01/07/26 SEK 2.400 0.00% 48,638
30/06/26 SEK 2.400 -4.38% 155,436
29/06/26 SEK 2.510 +0.40% 26,680

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENZY Stock